Jump Financial, LLC

Position in ARVN — Arvinas, Inc.

CIK 1831577 Chicago, IL

Position in ARVN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,461,155

+$1,042,685 QoQ

Shares Held

296,168

+121.3% QoQ

Ownership

0.453%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#35

of 198 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. ARVN ranks #54 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,461,155	296,168	+121.3%	Shares	Defined	2026-08-13
2026-03-31	$1,418,470	133,818	-28.9%	Shares	Defined	2026-05-14
2025-12-31	$2,232,894	188,271	+478.1%	Shares	Defined	2026-02-17
2024-09-30	$802,197	32,570	+2.5%	Shares	Defined	2024-11-14
2024-06-30	$845,504	31,762	+47.0%	Shares	Defined	2024-11-14
2023-12-31	$889,344	21,607	+104.0%	Shares	Sole	2024-10-21
2023-06-30	$262,843	10,590	-83.0%	Shares	Sole	2024-10-21
2023-03-31	$1,705,532	62,428	+364.4%	Shares	Sole	2024-10-21
2022-06-30	$565,815	13,443	+214.3%	Shares	Sole	2022-08-09
2022-03-31	$287,842	4,277	-84.9%	Shares	Sole	2022-05-12
2021-12-31	$2,324,562	28,300	+133.8%	Shares	Sole	2022-02-10
2020-12-31	$1,027,822	12,102	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.